Status: current, Defined. Date: 30-Nov 2009. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 980477691000036115 | 4-methylbenzylidene camphor 44 mg / 1 g + butyl methoxydibenzoylmethane 15 mg / 1 g + octyl methoxycinnamate 75 mg / 1 g + titanium dioxide 25 mg / 1 g cream, 100 g (medicinal product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 980477701000036115 | butyl methoxydibenzoylmethane 1.5% + 4-methylbenzylidene camphor 4.4% + octyl methoxycinnamate 7.5% + titanium dioxide 2.5% cream, 100 g | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| butyl methoxydibenzoylmethane 1.5% + 4-methylbenzylidene camphor 4.4% + octyl methoxycinnamate 7.5% + titanium dioxide 2.5% cream, 100 g | Is a | medicinal product pack | true | Inferred relationship | Some | ||
| butyl methoxydibenzoylmethane 1.5% + 4-methylbenzylidene camphor 4.4% + octyl methoxycinnamate 7.5% + titanium dioxide 2.5% cream, 100 g | has MPUU | butyl methoxydibenzoylmethane 1.5% + 4-methylbenzylidene camphor 4.4% + octyl methoxycinnamate 7.5% + titanium dioxide 2.5% cream | true | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Sunscreen SPF 30+ (Hamilton) cream, 100 g | Is a | True | butyl methoxydibenzoylmethane 1.5% + 4-methylbenzylidene camphor 4.4% + octyl methoxycinnamate 7.5% + titanium dioxide 2.5% cream, 100 g | Inferred relationship | Some |
Reference Sets
List of Excluded Medicinal Items reference set
Medicinal product pack reference set
FHIR